New Zealand markets open in 8 hours 12 minutes

Roche Holding AG (RHHBY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
40.47-0.15 (-0.37%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 272.58B
Enterprise value 294.06B
Trailing P/E 17.96
Forward P/E 15.65
PEG ratio (5-yr expected) 3.64
Price/sales (ttm)4.12
Price/book (mrq)10.10
Enterprise value/revenue 4.57
Enterprise value/EBITDA 12.74

Trading information

Stock price history

Beta (5Y monthly) 0.28
52-week change 3-13.34%
S&P500 52-week change 3-15.36%
52-week high 353.86
52-week low 337.88
50-day moving average 341.32
200-day moving average 344.99

Share statistics

Avg vol (3-month) 31.46M
Avg vol (10-day) 32.87M
Shares outstanding 56.4B
Implied shares outstanding 6N/A
Float 85.4B
% held by insiders 10.00%
% held by institutions 11.32%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.24
Forward annual dividend yield 43.05%
Trailing annual dividend rate 39.30
Trailing annual dividend yield 322.90%
5-year average dividend yield 42.99
Payout ratio 451.80%
Dividend date 327 Mar 2022
Ex-dividend date 416 Mar 2022
Last split factor 22:1
Last split date 326 Feb 2014

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 21.37%
Operating margin (ttm)30.92%

Management effectiveness

Return on assets (ttm)14.81%
Return on equity (ttm)43.78%

Income statement

Revenue (ttm)66.9B
Revenue per share (ttm)10.44
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)46.49B
EBITDA 23.95B
Net income avi to common (ttm)14.29B
Diluted EPS (ttm)2.26
Quarterly earnings growth (yoy)9.30%

Balance sheet

Total cash (mrq)6.81B
Total cash per share (mrq)1.06
Total debt (mrq)29.1B
Total debt/equity (mrq)100.52
Current ratio (mrq)1.11
Book value per share (mrq)3.93

Cash flow statement

Operating cash flow (ttm)21.62B
Levered free cash flow (ttm)13.64B